Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
After the expiration date, the preservative system is no longer guaranteed to work as intended
Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )
Seidu S, Kunutsor SK, Cos X, Gillani S, Khunti K, For et al
It should not be treated the same as FDA-approved obesity medications already available through standard medical channels
US$ 29.54
US$ 25.22
US$ 28.31
US$ 20.10
US$ 28.39
